Combination of Two Immune Cell Types Could Provide Clearer Prognoses for Cancer

Thanks to a new prognostic method for detecting cancers including cancer of the large intestine, doctors could provide clearer disease prognoses and predict which patients will respond best to immunotherapy. The method consists of a combination of two types of immune cells that characterize certain forms of cancer. This has been shown in a new study by researchers at Uppsala University and colleagues published on January 30, 2023 in eBioMedicine. The open-access article is titled “An Immune Score Reflecting Pro- and Anti-Tumoural Balance of Tumour Microenvironment Has Major Prognostic Impact and Predicts Immunotherapy Response in Solid Cancers.”